Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Recommendations

CHAPTER SECTIONS

Collateral Findings


Section 4

Recommendations

Expand Contributors

Stephanie R. Morain, PhD
For the NIH Pragmatic Trials Collaboratory Ethics and Regulatory Core

Contributing Editor

Damon M. Seils, MA

Anticipate and Plan for Collateral Findings Before Study Implementation

Investigators should prospectively consider the potential for collateral findings in pragmatic clinical trials during study design and work with their partnering healthcare institutions to understand processes for managing any collateral findings that might arise.

IRBs can support research teams in prospective consideration of potential collateral findings in pragmatic trials by ensuring that investigators have a management plan at the time of study review. However, IRB members should be aware that, because many pragmatic trials are conducted with waivers or alterations of informed consent, individuals may not have previously had the opportunity to consider their preferences for receiving additional information related to their health. As a result, informed consent will likely have limited value as a solution for decision making regarding disclosure of collateral findings in pragmatic trials.

Prepare Clinicians to Discuss Collateral Findings With Patients

Frontline clinicians in the healthcare systems in which pragmatic trials are embedded will play a key role in the disclosure and management of collateral findings. Healthcare systems should prepare clinicians accordingly. Relevant components include preparing to discuss with patients the rationale for pragmatic trials (and for conducting at least some pragmatic trials without prospective informed consent), responding to negative reactions from patients regarding disclosure, and directing patients to appropriate resources within their institution for management and follow-up.

Use Multiple Modes to Communicate About Collateral Findings to Patients

When communicating information about collateral findings in pragmatic trials to patients, healthcare systems should consider using multiple channels, from electronic notifications through patient portals to phone calls or in-person visits. Using multiple approaches recognizes the heterogeneity of patients’ informational preferences, as well as differences in their access to relevant communication modes.

Previous Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. The Challenge of Collateral Findings
  3. Stakeholder Perspectives
  4. Recommendations

Resources

Screenshot from Grand Rounds slides

Ethics and Collateral Findings in Pragmatic Clinical Trials: Implications of a Multi-Method Exploration; NIH Pragmatric Trials Collaboratory Grand Rounds; May 13, 2022


Version History

June 23, 2025: Made nonsubstantive changes to the text as part of the regular content review (changes made by D. Seils).

Published October 13, 2022 (by D. Seils).

current section :

Recommendations

  1. Introduction
  2. The Challenge of Collateral Findings
  3. Stakeholder Perspectives
  4. Recommendations

Citation:

Morain SR; for the NIH Pragmatic Trials Collaboratory Ethics and Regulatory Core. Collateral Findings: Recommendations. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/ethics-and-regulatory/collateral-findings/recommendations/. Updated June 23, 2025. DOI: 10.28929/160.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map